Form 4 for AURA Aura Biosciences, Inc.
Accepted 2026-05-19 16:59:48 ET · period of report 2026-05-19 · accession 0001580111-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-19 16:59 | 2026-05-19 | AURA | Holles Natalie C. | See Remarks, Dir | A - Grant | $0.00 | +1.15M | 1.15M | New | $0 |
| D | 2026-05-19 16:59 | 2026-05-19 | AURA | Holles Natalie C. | See Remarks, Dir | A - Grant | $0.00 | +2.17M | 2.17M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | A | A | 600,118 | $0.00 | 600,118 | D | — | — | (F1) These shares were acquired pursuant to a restricted stock unit ("RSU") award as Inducement Awards. Each RSU represents the right to receive one share of the Issuer's common stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. |
| 2 | Common | Common Stock | 2026-05-19 | A | A | 553,844 | $0.00 | 1,153,962 | D | — | — | (F2) These shares were acquired pursuant to a performance RSU ("PRSU") award as Inducement Awards. The PRSUs are subject to both time-based vesting and the achievement of a performance condition, both of which must be satisfied before the PRSUs will be deemed vested. The PRSUs shall vest in four substantially equal annual installments commencing on April 15, 2027, subject to Ms. Holles' continued service as of each such time-based vesting date and the satisfaction of the performance condition. The expiration date of the PRSUs is the earlier of (i) the sixth (6th) anniversary of the grant date and (ii) the date Ms. Holles no longer has a service relationship with the Issuer. Any such PRSUs that have not vested on or prior to such expiration date shall be forfeited for no consideration. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-05-19 | A | A | 2,169,103 | $0.00 | 2,169,103 | D | $7.39 · — to 2036-05-19 | 2,169,103 Common Stock | (F3) The shares underlying this option vest as follows: 25% of the shares vest on April 30, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. |